期刊文献+

内异康复栓对子宫内膜异位症大鼠异位和在位内膜雌、孕激素受体的影响 被引量:4

Influence of Neyikangfu Suppository on Estrogen Receptors and Progesterone Receptors in Ectopic and Eutopic Endometrium of Endometriosis Model Rats
下载PDF
导出
摘要 目的观察内异康复栓直肠给药对子宫内膜异位症大鼠异位和在位内膜雌激素受体(ER)、孕激素受体(PR)表达的不同影响,探讨其作用机理。方法将子宫内膜异位症大鼠随机分为内异康复栓高、中剂量组及丹那唑组、丹莪妇康煎膏组、模型组、空白组,采用免疫组化SP法检测ER、PR的表达。结果内异康复栓高、中剂量组能显著降低异位内膜ER、PR的表达(P<0.05),并对在位内膜下降的ER、PR水平有上调作用(P>0.05)。结论内异康复栓可能通过抑制异位内膜细胞内ER、PR的合成而发挥治疗作用,且对在位内膜异常的ER、PR表达有一定的调节作用。 Objective To explore the different influence of Neyikangfu suppository (NYKFS) on ER and PR in ectopic and eutopic endometrium of endometriosis model rats by treatment of rectal administration. Methods Healthy and sexual matured female SD rats were taken as the researching objects and endometriosis model were achieved by autologous operation transplantation. Six groups were randomly formed and which were high-dose and middle-dose groups of NYKFS, Danazol capsule group and Danefukangjiangao (DEFKJG) group, model group and normal control group. Expressions of ER and PR in ectopic and eutopic endometrium and endometrium of normal group was measured by immunohistochemical SP staining method. Results High-dose and middle-dose groups of NYKFS could obviously lower the expression of ER and PR in ectopic endometrium of endometriosis model rats. High-dose and middle-dose groups of NYKFS could increase the expression of ER and PR in eutopic endometrium to certain extent (P〉0.05). Conclusions NYKFS can inhibit the synthesis of ER and PR in cells of ectopic endometrium to treat endometriosis and have certain accommodation on abnormal expression of ER and PR in eutopic endometrium.
出处 《中国中医药信息杂志》 CAS CSCD 2007年第11期25-27,共3页 Chinese Journal of Information on Traditional Chinese Medicine
基金 四川省科技厅科学基金资助(05JY029-075-1)
关键词 子宫内膜异位症 内异康复栓 雌激素受体 孕激素受体 大鼠 endometriosis Neiyikangfu suppository estrogen receptors progesterone receptors rat
  • 相关文献

参考文献9

二级参考文献22

  • 1肖纯,黄桂林,彭泽华,匡冰.大鼠实验性子宫内膜异位症模型复制[J].中国病理生理杂志,1995,11(3):332-333. 被引量:20
  • 2常乐,王为服,邵公权.子宫内膜异位症不孕的内分泌因素[J].生殖与避孕,1996,16(5):393-395. 被引量:4
  • 3王俊玲,罗元恺.罗氏内异方治疗子宫内膜异位症附:40例病例报告[J].成都中医药大学学报,1996,19(2):18-21. 被引量:13
  • 4顾玲芬,张丽珠,顾方颖,耿力,王泽密.子宫内膜异位症异位与在位内膜发育日期及雌、孕激素受体水平[J].中华妇产科杂志,1996,31(10):582-585. 被引量:14
  • 5曹泽毅.中华妇产科学[M].北京:人民卫生出版社,1999.2129.
  • 6isolle M, Casasanas-Roux F, Donnez J. Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis[J]. Fertil Steril, 1977,68:912~919.
  • 7Bergquest A. Estrogen and progesterone receptors in endometriotic tissue and endometrium: comparison according to localization and recurrence[ J ]. Fertil Steril, 1993,60: 63.
  • 8Jones RC. The effect of a luteinizing hormone releasing hormone(LRH) agonist (Wy-40,972),levonorgestrel, danazol and ovariectomy on experimental endometriosis in the rat[J]. Acta Endocrinologica, 1984,106(2):282-288.
  • 9Vinatier D, Cosson M, Dufour P. Is endometriosis an endometrial disease? [J]. Eu J Obstet Gynecol Reprod Biol,2000,91(1):113-125.
  • 10Koninckx PR, Kennedy SH, Barlow DH. Endometriotic disease: the role of peritoneal fluid[J]. Hum Reprod Update,1998,4(3):741-751.

共引文献50

同被引文献51

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部